-
Omalizumab, sold
under the
brand name
Xolair among others, is an
injectable medication to
treat severe persistent allergic forms of asthma,
nasal polyps...
- in
allergic reactions. The
efficacy of
omalizumab may vary
among patients. To
identify responders to
omalizumab, the
level of
several biomarkers can be...
-
includes the use of antihistamines, corticosteroids,
monoclonal antibodies (
omalizumab), and in some cases,
immunosuppressive drugs.
Despite ongoing research...
- control. Experimentally, a low dose of
methotrexate or
cyclosporin and
omalizumab (a
monoclonal anti-IgE antibody) has been used.
Treatment of autoimmune...
- long-term
antihistamine therapy is indicated.
Immunosuppressants such as
omalizumab or
cyclosporin may also be used.
About 20% of
people are
affected at some...
-
phase I to IV
clinical trials of
omalizumab in
various indications,
concluded that a
causal relationship between omalizumab therapy and
malignancy is unlikely...
- off-label
therapy with
cyclosporine A or
montelukast or add-on
therapy with
omalizumab,
which is an
approved treatment option for CSU. Angioedema, excruciatingly...
-
cells and
thereby help
prevent acute rejection of
kidney transplants.
Omalizumab inhibits human immunoglobulin E (IgE) and is
useful in
treating moderate-to-severe...
- CU is
rather limited in most cases. Treatment(s) with
mixed success:
omalizumab (anti-IgE therapy),
danazol (synthetic androgen),
propranolol (beta blocker)...
-
approaches to
reducing autumn exacerbations, but
while costly,
seasonal omalizumab treatment from four to six w****s
before school return may
reduce autumn...
